HOME >> MEDICINE >> NEWS
Mistletoe is not an anti-cancer drug, say doctors

The belief that mistletoe can help treat cancer is a myth which can cause harm, warn doctors in this week's Christmas issue of the BMJ.

The warning follows the case of a cancer patient who attended hospital with a tumour-like growth under the skin induced by mistletoe.

Some patients with cancer inject themselves mistletoe extract in the hope of improving their condition, writes complementary medicine expert, Professor Edzard Ernst in an accompanying editorial. In continental Europe, at least 30 different mistletoe preparations are available and in Germany, the insurance system pays for this treatment. A Google search also showed that 145,000 websites promote or mention mistletoe as a treatment for cancer.

So, is mistletoe an effective anticancer drug and how safe is it?

The theory that mistletoe might help treat cancer is based on the fact that, like cancer, mistletoe is a parasitic growth that eventually kills its host, says Ernst. Despite the implausibility of this idea, studies have shown that mistletoe or its main constituents do have anticancer activity. However, many plants have some sort of anticancer activity, but in most cases the compounds cannot be used.

Proponents claim that regular injections of mistletoe extract improve the natural course of cancer by slowing down or stopping tumour growth and improve quality of life.

Yet a wide range of serious adverse reactions have been noted, such as anaphylaxis, breathing difficulties, joint pain and kidney failure. Some studies even suggest that mistletoe extract may enhance the proliferation of some cancers.

So the claim that mistletoe injections have no serious risks is misleading, argues Ernst.

Mistletoe has been tested extensively as a treatment for cancer, but the most reliable trials fail to show benefit, and some reports show considerable potential for harm. The costs of regular mistletoe injections are also high.

'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
21-Dec-2006


Page: 1 2

Related medicine news :

1. New algorithm matches any tumor cells to best possible anti-cancer treatments
2. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
3. Vorinostat shows anti-cancer activity in recurrent gliomas
4. Research says boiling broccoli ruins its anti-cancer properties
5. Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
6. Erectile dysfunction drugs heighten natural anti-cancer activity
7. New litmus test could aid discovery of anti-cancer drugs
8. Derivatives of cannabis for anti-cancer treatment win Kaye Award for Hebrew University student
9. Risks outweigh benefits of shark cartilage as anti-cancer treatment
10. New method of administering anti-cancer drug may be more effective, safer
11. Innovative study finds way to bio-synthesize an anti-cancer compound

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... 2017 , ... After a summer-long contest to crown the ... Drivers proudly announced the winners of the HEROtini Mocktail Challenge at the Stockton ... the challenge of competing in three categories: Best HEROtini Mocktail, Top HEROtini Bartender, ...
(Date:9/26/2017)... ... , ... Data Integrity: , The Key to FDA and GMP Compliance, ** ... http://www.fdanews.com/fdadataintegrity , Consider this situation. The FDA gives simple ... be trustworthy and reliable … a more detailed evaluation may be warranted.” , ...
(Date:9/26/2017)... ... 26, 2017 , ... Dr. Kovatis, is a Hospital for ... and Foot Section of the Department of Orthopedic Surgery at Hackensack University Medical ... UMC performing total ankle replacements. Because of this, Dr. Kovatis is often referred ...
(Date:9/26/2017)... , ... September 26, 2017 , ... The 2017 American ... called “The Magic of Fat,” revealed not only the latest about cosmetic procedures to ... be an evolution in cosmetic medicine. , “Fat really is magical, especially when it ...
(Date:9/26/2017)... ... 26, 2017 , ... The Organizing Committee is pleased to ... Pittcon 2018. As of July 1, Adrian C. Michael, Ph.D. (University of Pittsburgh, ... Charles Gardner, (ChemImage Corporation) and selected chairs. , Other members of ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/7/2017)...  Eli Lilly and Company (NYSE: ... to more efficiently focus resources on developing new ... workforce reductions, including those from a U.S. voluntary ... 3,500 positions. With the streamlining ... approximately $500 million that will begin to be ...
Breaking Medicine Technology:
Cached News: